Pavlovian Conditioned Approach, conditioned reinforcement, sign-tracking, number of lever presses (contacts) during the conditoned reinforcement session
Tags: Behavior · Pavlovian conditioned approach · Conditioned reinforcement
Project: p50_paul_meyer_2014
1 locus · 5 genes with independent associations · 151 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | chr1 | 151412751 | 157139855 | 151 | 5 | 1.92e-09 | 3.33e-09 | 1e+00 | Arap1 Capn5 LOC102553078 LOC120099890 Mrpl48 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 13 | 0.4 | 1.33 |
Adipose | alternative TSS | 12 | 0.4 | 1.46 |
Adipose | gene expression | 12 | 0.1 | 1.35 |
Adipose | isoform ratio | 13 | 0.3 | 1.38 |
Adipose | intron excision ratio | 3 | 0.1 | 1.23 |
Adipose | mRNA stability | 9 | 0.2 | 1.36 |
BLA | alternative polyA | 2 | 0.1 | 1.42 |
BLA | alternative TSS | 7 | 0.4 | 1.43 |
BLA | gene expression | 10 | 0.1 | 1.4 |
BLA | isoform ratio | 0 | 0 | 1.4 |
BLA | intron excision ratio | 2 | 0.1 | 1.33 |
BLA | mRNA stability | 4 | 0.2 | 1.38 |
Brain | alternative polyA | 2 | 0.1 | 1.35 |
Brain | alternative TSS | 5 | 0.1 | 1.32 |
Brain | gene expression | 12 | 0.1 | 1.36 |
Brain | isoform ratio | 5 | 0.1 | 1.35 |
Brain | intron excision ratio | 7 | 0.1 | 1.29 |
Brain | mRNA stability | 8 | 0.1 | 1.35 |
Eye | alternative polyA | 0 | 0 | 1.27 |
Eye | alternative TSS | 2 | 0.5 | 1.47 |
Eye | gene expression | 3 | 0.2 | 1.42 |
Eye | isoform ratio | 0 | 0 | 1.29 |
Eye | intron excision ratio | 1 | 0.1 | 1.38 |
Eye | mRNA stability | 0 | 0 | 1.34 |
IL | alternative polyA | 0 | 0 | 1.24 |
IL | alternative TSS | 0 | 0 | 1.29 |
IL | gene expression | 5 | 0.1 | 1.4 |
IL | isoform ratio | 0 | 0 | 1.38 |
IL | intron excision ratio | 1 | 0.1 | 1.26 |
IL | mRNA stability | 0 | 0 | 1.34 |
LHb | alternative polyA | 0 | 0 | 1.35 |
LHb | alternative TSS | 0 | 0 | 1.42 |
LHb | gene expression | 1 | 0 | 1.37 |
LHb | isoform ratio | 2 | 0.2 | 1.31 |
LHb | intron excision ratio | 0 | 0 | 1.27 |
LHb | mRNA stability | 0 | 0 | 1.28 |
Liver | alternative polyA | 1 | 0 | 1.26 |
Liver | alternative TSS | 4 | 0.1 | 1.36 |
Liver | gene expression | 12 | 0.2 | 1.41 |
Liver | isoform ratio | 6 | 0.2 | 1.33 |
Liver | intron excision ratio | 8 | 0.2 | 1.36 |
Liver | mRNA stability | 2 | 0.1 | 1.34 |
NAcc | alternative polyA | 2 | 0.1 | 1.41 |
NAcc | alternative TSS | 5 | 0.2 | 1.33 |
NAcc | gene expression | 8 | 0.1 | 1.4 |
NAcc | isoform ratio | 4 | 0.1 | 1.37 |
NAcc | intron excision ratio | 3 | 0.1 | 1.3 |
NAcc | mRNA stability | 6 | 0.2 | 1.38 |
OFC | alternative polyA | 0 | 0 | 1.27 |
OFC | alternative TSS | 0 | 0 | 1.34 |
OFC | gene expression | 2 | 0 | 1.38 |
OFC | isoform ratio | 2 | 0.1 | 1.36 |
OFC | intron excision ratio | 0 | 0 | 1.2 |
OFC | mRNA stability | 1 | 0.1 | 1.43 |
PL | alternative polyA | 7 | 0.2 | 1.51 |
PL | alternative TSS | 3 | 0.1 | 1.35 |
PL | gene expression | 11 | 0.1 | 1.38 |
PL | isoform ratio | 4 | 0.1 | 1.37 |
PL | intron excision ratio | 3 | 0.1 | 1.33 |
PL | mRNA stability | 4 | 0.1 | 1.37 |
pVTA | alternative polyA | 2 | 0.1 | 1.4 |
pVTA | alternative TSS | 3 | 0.2 | 1.34 |
pVTA | gene expression | 8 | 0.2 | 1.39 |
pVTA | isoform ratio | 4 | 0.2 | 1.36 |
pVTA | intron excision ratio | 4 | 0.1 | 1.32 |
pVTA | mRNA stability | 3 | 0.2 | 1.35 |
RMTg | alternative polyA | 0 | 0 | 1.27 |
RMTg | alternative TSS | 0 | 0 | 1.32 |
RMTg | gene expression | 0 | 0 | 1.34 |
RMTg | isoform ratio | 0 | 0 | 1.23 |
RMTg | intron excision ratio | 0 | 0 | 1.45 |
RMTg | mRNA stability | 0 | 0 | 1.35 |